Crossmark

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib

Published Online: 2017-07-10

Published Print: 2017-10

Authors

Sopper, S

Mustjoki, S

Gjertsen, B T

Giles, F

Hochhaus, A

Janssen, J J W M

Porkka, K

Wolf, D
License Information

Text and Data Mining valid from 2017-07-10

Version of Record valid from 2017-07-10
More Information

Article History

First Online: 10 July 2017

Competing interests

: All authors received research support from Novartis.

Document is current